Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Astrivax N.V.
See Emerging Company Profile .
BioCentury | Mar 19, 2024
Management Tracks
Arvinas hires Berkowitz as CMO
Plus: BoA veteran Setia joins MapLight as CFO, and updates from Ocugen, Clearside, Telum, SmartCella, AstriVax and Solu
BioCentury | Oct 10, 2023
Management Tracks
Amgen veteran Lenz named head of R&D at Neumora
Plus: Eaton leaving Editas as CTO, CBO and updates from Poseida, Zevra, Pheon, Lexicon and more
BioCentury | Oct 20, 2022
Management Tracks
5AM hires Anna Yaeger as head of public equities
Plus Scripps alum Maricich becomes Ashvattha CMO and updates from Alexion, Rewind, ExeVir and more
BioCentury | Sep 26, 2022
Management Tracks
AZ veteran Julie Brown becomes CFO at GSK
Plus AstriVax appoints chair and updates from Section 32, Janux and Alivamab
BioCentury | Sep 26, 2022
Emerging Company Profile
AstriVax: thermostable, plug-and-play vaccines using plasmids
V-Bio Ventures and Fund+ lead €30M seed round for KU Leuven spinout
Items per page:
1 - 5 of 5